Skip to content

CLINICAL EVALUATION OF TOPICAL SIMVASTATIN GEL FOR TREATMENT OF CHRONIC WOUNDS

CLINICAL EVALUATION OF TOPICAL SIMVASTATIN GEL FOR TREATMENT OF CHRONIC WOUNDS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202001800892609
Enrollment
35
Registered
2020-01-13
Start date
2017-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases

Interventions

Topical application of simvastatin gel
Topical application of phenytoin aerosol

Sponsors

Department of vascular surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Diabetic foot ulcer, venous ulcer or post-surgery wound for more than 4 weeks. ? Clean non healing wound for more than 4 weeks. ? Age group 40-60 years, both male and female.

Exclusion criteria

Exclusion criteria: ? Uncontrolled diabetics. ? Presence of vascular impairment. ? Associated co-morbidity such as hepatic and renal diseases. ? Patients with allergy to Phenytoin or Simvastatin. ? Infected wound. ? Pregnant women. ? Patient who had an unstable psychological profile.

Design outcomes

Primary

MeasureTime frame
On day 14 of treatment period, simvastatin treated patients showed complete healing of wounds in eight patients (44.4%), while only four patients (23.4%) showed complete wound healing in phenytoin treated patients.

Secondary

MeasureTime frame
At the end of the treatment period (Four weeks), complete healing was evident in 13 patients (72%) of simvastatin group and 9 patients (52.9%) in phenytoin group. Patient who showed partial healing of their wounds were 4 patients (22.2%) in the study group versus 5 patients (29.4%) in the phenytoin group (positive control). Patient who showed no improvement were 2 patients (11.7%) in the phenytoin group versus no patient in the study group.

Countries

Egypt

Contacts

Public ContactMOHAMED RAOUF

Critical care pharmacist

MMOHAMEDALI@KFSHRC.EDU.SA00966591961748

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026